Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-08

Clinical Trial Update: Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions

View source ↗

Summary

Update on a trial assessing the safety and efficacy of a drug-coated balloon for superficial femoral artery ischemic vascular disease in patients with complex T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drug-Coated Balloon (DCB) (drug-coated balloon)

Snippet

Sponsor: Ettore Sansavini Health Science Foundation | Conditions: PAD | Status: UNKNOWN